As Pharmaceutical Industry Increases Use of Investigator Initiated Trials (IIT), Companies are Struggling to Effectively Manage IIT Programs

Saturday, December 2, 2017 Drug News
Email Print This Page Comment bookmark
Font : A-A+

CHAPEL HILL, N.C., Dec. 1, 2017 /PRNewswire/ -- Pharmaceutical companies are investing more resources in investigator initiated

trials (IITs) as they strive to expand their commercial opportunities.

Yet as organizations strive to improve and expand their IIT programs, they are struggling to ensure IIT proposals align with corporate objectives and also demonstrate scientific

merit. Likewise, a significant increase in the number of IIT submissions necessitates that organizations manage their IIT programs effectively to not let costs leapfrog results.

One of the keys to overcoming these internal challenges is the use of a separate, dedicated team to manage IITs, according to a new study from pharmaceutical research leader Best Practices, LLC. "We are going to allocate specific people dedicated solely to IITs as it will work better. This can ensure that the investigators keep up the deal at their end by working with them and making sure they stay on track to complete that timeline," said an executive director of IIT trial management who participated in the study.

The report that grew out of the research study, "Investigator Initiated Trials Management," presents current industry metrics on key aspects of IIT program management, including IIT team structure, staffing, budget and performance metrics.

This 60-page report serves as a reference point for those who oversee or work in investigator initiated trials so that they can compare the critical aspects of their IIT program with industry peers.

Topics addressed in the study include:

  • IIT Submission Review and Systems
  • Functional Involvement
  • IIT Funding
  • IIT Audit
  • Future Improvements
  • Important Criteria for IIT Evaluation
  • Key Reasons for Rejecting IIT Proposals

Best Practices, LLC engaged 30 leaders from 23 bio-pharmaceutical and medical device companies through a benchmarking survey. In addition, four leaders in IIT management were interviewed to provide qualitative data.

To learn more about this report, download a complimentary report excerpt at http://www.best-in-class.com/rr1475.htm.

For related research, visit the Best Practices, LLC Web site at www.best-in-class.com/. 

ABOUT BEST PRACTICES, LLCBest Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis.

 

View original content:http://www.prnewswire.com/news-releases/as-pharmaceutical-industry-increases-use-of-investigator-initiated-trials-iit-companies-are-struggling-to-effectively-manage-iit-programs-300565424.html

SOURCE Best Practices, LLC



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store